Position in FDMT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,706,602
+$1,054,000 QoQ
Shares Held
128,316
+83.1% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,175,833 across 370 Biotechnology names. FDMT ranks #202 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in FDMT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,706,602 | 128,316 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $652,602 | 70,097 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $492,367 | 65,649 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $569,803 | 65,570 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $230,264 | 62,066 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,406 | 7,866 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,373 | 2,042 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $44,321 | 4,100 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $21,330,520 | 1,016,223 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $30,868,579 | 968,882 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $73,685 | 3,637 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $35,083 | 2,756 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $51,174 | 2,832 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $46,309 | 2,694 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $597,493 | 26,902 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,317,159 | 288,204 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,889,154 | 700,452 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,499,215 | 1,091,218 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,015,438 | 1,140,175 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,562,610 | 1,021,973 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $24,988,441 | 1,037,726 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $55,854,829 | 1,287,571 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $66,086,014 | 1,594,355 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||